Purpose To investigate the mean changes over time in health-related quality of life among advanced cancer patients who did not receive any intervention, comparing changes among all patients versus changes in subgroups of patients with high initial symptom scores. Methods Patients with advanced cancer answered two questionnaires, containing the EORTC QLQ-C30 (15 multi-or single-item scales), with approximately 1 month in between and received no known intervention in between. For each QLQ-C30 scale, we estimated the mean change among all patients and in subgroups of patients scoring at least 33, 50, and 66 %, respectively, of maximum (maximal symptom score or maximally reduced function score) in the first questionnaire. Results In total, 1014 patients completed both questionnaires. As hypothesized, we found no change over time in mean scores when including all patients [average mean change = -0.9 (95 % CI -1.5;-0.6)]. In the subgroups of patients initially scoring at least 33, 50, or 66 % of maximum, the score improved with mean changes of -9.2 (95 % CI -10.1;-8.4), -13.1 (95 % CI -14.4;-11.8), and -15.6 (95 % CI -17.2;-13.9), respectively.
Introduction
Identifying patients who have symptoms and problems and who are therefore considered in need for additional service may enable appropriate referral and maximize effective utilization, e.g., utilization of psychosocial services, a view that is supported by clinical practice guidelines [1] . For example, in trials of psychosocial interventions in cancer patients, studies have found that the largest improvements in psychological distress, cognitive impairment, and quality of life can be expected among patients with high initial levels of distress [2] .
Therefore, quite sensibly, trials investigating the effect of a psychosocial intervention may often wish to preselect patients, who the researchers believe may benefit from the intervention. Generally, a target population is first determined and then individuals with a level of distress above a certain threshold within that population are included. However, one might assume that when screening patients, and thereby grouping individuals according to their initial high level of distress, the patients may reach a more average level over time-even without an intervention. This may be because those with high initial distress have a greater opportunity to improve than individuals with less extreme scores. It may also be because symptoms and problems have a tendency to pass, because patients will seek treatment outside the intervention investigated due to their distress, or the high score may be an error, e.g., if the patient has selected the wrong response option.
We could think of this potential change among patients with high initial scores as a regression toward the mean (RTM), although this is not the standard use of the term. RTM is the tendency for a variable that is extreme on its first measurement will tend to be closer to the average on its second measurement [3] . Thus, the concept might explain why individuals with the greatest symptoms at baseline have a greater opportunity to improve than individuals with less extreme scores.
To our knowledge, no papers have investigated the mean changes in symptoms and problems over time in advanced cancer patients with higher initial scores who did not receive an intervention. The purpose of this paper was therefore to empirically investigate this mean change over time (which could be thought of as a potential RTM) for subgroups of patients with different levels of levels of distress at first assessment.
Our hypotheses were:
(1) The correlations between repeated measurements of symptoms or problems with a month in between are moderate to high when including all patients in the sample, indicating relatively minimal change in the measurements within subjects. (2) The average level of symptoms and problems in a cross-sectional sample of cancer patients not receiving any intervention is not different 1 month later, indicating no mean change. (3) There are substantial mean changes over time when including only patients having high initial scores.
Method Patients
The inclusion of patients has been described previously [4, 5] . To achieve a random and representative sample, we included patients from three out of 14 
Design and intervention
Patients received the first questionnaire at a random time that was not affected by their treatment status or their contact to the hospital. Approximately 2 weeks after the first questionnaire was received by the research coordinator, an additional questionnaire was sent to the patients. Between the first and the second questionnaire, no intervention was initiated based on the study. Thus, we expected the same level of distress in the two assessments, as the patients were contacted at a random time unrelated to their treatment.
Questionnaires
The EORTC QLQ-C30 [7] was administered at both occasions. It assesses health-related quality of life and consists of nine multi-item scales measuring: physical function, role function, emotional function, cognitive function, social functioning, global health status/quality of life, fatigue, nausea and vomiting, and pain, and six singleitem scales measuring: dyspnoea, insomnia, lack of appetite, constipation, diarrhea, and financial difficulties. For symptom scales a high score indicates more symptoms (the higher the worse). For function scales a high score represents better functioning (the higher the better).
Statistical analyses
The data were analyzed with SAS statistical software, version 9.4 [8] .
The answers to the EORTC QLQ-C30 were converted to 0-100 scales according to the scoring manual [9] .
We estimated the intraclass correlation between the first and second questionnaire for each of the 15 scales in the EORTC QLQ-C30 using the total sample. The interclass correlation coefficient is equivalent to the quadratic weighted kappa, and a coefficient of 1 indicates maximum possible correlation, whereas a coefficient of 0 indicates no correlation [10] .
We calculated the mean change over time for each of the 15 scales in the EORTC QLQ-C30. First, we did this including all patients who had answered the two questionnaires in order to test hypothesis 1. Second, we investigated the mean change for patients who had scored at least 33, 50, or 66 %, respectively, of what corresponds to ''maximum distress score'' (for a symptom scale, this corresponds to a score of 100; for a function scale and global health status/QoL, this corresponds to a score of 0) in the first questionnaire. A score of 33 % corresponds to an average response of ''a little'' (symptom/problem) to the items in a scale, 50 % is in the middle of the scale, and 66 % corresponds to ''quite a bit'' symptom/problem. The 95 % CI was estimated using an asymptotic method.
Results

Participants
The first questionnaire was completed by 1447 patients, and 1014 of these patients also completed the second questionnaire with a mean of 31 days in between (SD 15.5 days). Table 1 shows the baseline characteristics of the 1014 patients who completed both questionnaires.
As hypothesized, when including all patients there was a moderate-to-high correlation between the first and second measurements of the 15 scales ranging from 0.55 (95 % CI 0.48;0.62) to 0.89 (95 % CI 0.87;0.91) ( Table 2) .
As hypothesized, there were very small changes over time in the 15 scales ranging from -1.9 to 2.1; the mean change across scales was -1.0 (95 % CI -1.5;-0.6) ( Table 3) .
The mean change for increasing cutoff values is shown in Table 3 . As hypothesized, there were substantial changes over time in patients with high initial scores. The mean change across all scales increased with higher cutoff threshold for initial scores from mean -9.2 (95 % CI -10.1;-8.4) for cutoff at least 33 % to -15.6 (95 % CI -17.2;-13.9) for cutoff at least 66 % of maximum score.
The largest change was observed for nausea/vomiting: -20.3 (95 % CI -24.9;-15.7), -29.4 (95 % CI -37.3; -21.5) and -37.9 (95 % CI -49.2;-26.7), for patients scoring at least 33, 50, or 66 % of maximum initial score (Table 3) , respectively. Figure 1 shows the distribution of scores for nausea/vomiting at the two assessments among patients scoring at least 33 % of maximum score in the first questionnaire. Obviously, there are therefore no observations below 33 at the first assessment, and the histogram exemplifies how the level of symptoms is more evenly distributed at the second measurement.
Among functional scales, the largest change was for social functioning: 12.6 (95 % CI 10.2;15.0), 17.7 (95 % CI 14.4;20.9), and 19.8 (95 % CI 15.6;24.0) for patients initially scoring 33, 50, or 66 % of maximum distress, respectively.
Discussion
The present study provides data supporting our three hypotheses of (1) moderate-to-high correlations between the first and second assessment of symptoms and problems, (2) no mean change over time in the total sample of advanced cancer patients, and (3) substantial changes over time in patients having high initial scores with larger changes for higher cut-points. We used data for change over time in the 15 scales of the EORTC QLQ-C30 from a large sample of presumably stable cancer patients. To the best of our knowledge, this is the first study to empirically investigate the change over time in symptoms and problems, according to various cut-points, in advanced cancer patients, who did not receive an intervention. Our findings showed moderate-to-high correlations between the first and second measurements of symptom and problems and very small changes over time when including all patients in the analysis. This confirmed that, overall, patients were stable. However, when selecting patients with initial high levels of distress, we found large mean changes. The largest change was found for nausea/ vomiting with mean changes of -20.3 to -37.9.
These findings can be interpreted as the hypothesized regression toward the mean (RTM). RTM has already received considerable attention in research concerning the determination of clinical significant changes and has been reported in studies measuring blood pressure and cholesterol, where any two observations are rarely identical and higher initial values are likely to be followed by an observation closer to the person's average value [11] [12] [13] . Furthermore, RTM has been discussed regarding the use of growth curve modelling of psychotherapy outcomes, which can be used to estimate an expected treatment response for patients, making it possible to allocate treatment to the patients with the highest needs and who will benefit the most [14, 15] .
We believe that the mean changes found in this study cannot be viewed as a result of RTM in its traditional meaning, but could also be caused by a variety of reasons including placebo effects, patients seeking treatment on their own initiative, or patients simply getting accustomed to the distress. This illustrates that if patients with high initial scores are offered intervention, it may be difficult to distinguish a treatment effect from changes in symptoms and problems caused by other reasons than the intervention.
A limitation of the study could be the missing data. Not all patients filled in the second questionnaire. It is possible that the patients who had the worst symptoms and problems at the second measurement did not answer the second questionnaire, and this may bias the results. However, results are still applicable to the interpretation of other questionnaire studies where the same attrition is likely to occur.
In conclusion, this study has produced estimates of the magnitude of mean changes for advanced cancer patients when subgroups having high initial scores are followed over a period of approximately 1 month. The findings contribute to the understanding of the dynamic nature of symptoms and problems, which is essential when interpreting results from clinical studies. Failure to acknowledge a mean change occurring as a result of preselecting patients with initially high levels of distress may lead to wrong conclusions if changes over time are solely interpreted as effects of intervention.
